| 000 | 01555 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514164657.0 | ||
| 264 | 0 | _c20040401 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a0161-813X | ||
| 024 | 7 |
_a10.1016/S0161-813X(03)00100-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHamaue, N | |
| 245 | 0 | 0 |
_aComparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus. _h[electronic resource] |
| 260 |
_bNeurotoxicology _cJan 2004 |
||
| 300 |
_a205-13 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 | _aEncephalitis Virus, Japanese |
| 650 | 0 | 4 |
_aHypokinesia _xdrug therapy |
| 650 | 0 | 4 |
_aIsatin _xchemistry |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xchemistry |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSelegiline _xchemistry |
| 700 | 1 | _aMinami, M | |
| 700 | 1 | _aTerado, M | |
| 700 | 1 | _aHirafuji, M | |
| 700 | 1 | _aEndo, T | |
| 700 | 1 | _aMachida, M | |
| 700 | 1 | _aHiroshige, T | |
| 700 | 1 | _aOgata, A | |
| 700 | 1 | _aTashiro, K | |
| 700 | 1 | _aSaito, H | |
| 700 | 1 | _aParvez, S H | |
| 773 | 0 |
_tNeurotoxicology _gvol. 25 _gno. 1-2 _gp. 205-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0161-813X(03)00100-1 _zAvailable from publisher's website |
| 999 |
_c14428430 _d14428430 |
||